Yao Yi-yun, T. Yong, Zhuang Yan, W. Lei, Zou Li-fang, Z. Qi
{"title":"间歇性给药valacyclovir可有效预防用硼替佐米治疗的多发性骨髓瘤患者的带状疱疹事件","authors":"Yao Yi-yun, T. Yong, Zhuang Yan, W. Lei, Zou Li-fang, Z. Qi","doi":"10.3969/J.ISSN.1007-3969.2014.07.009","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10041,"journal":{"name":"中国癌症杂志","volume":"24 1","pages":"525-528"},"PeriodicalIF":0.0000,"publicationDate":"2014-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Intermittent administration of valacyclovir is effective for prevention of herpes zoster events in patients with multiple myeloma treated with bortezomib\",\"authors\":\"Yao Yi-yun, T. Yong, Zhuang Yan, W. Lei, Zou Li-fang, Z. Qi\",\"doi\":\"10.3969/J.ISSN.1007-3969.2014.07.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10041,\"journal\":{\"name\":\"中国癌症杂志\",\"volume\":\"24 1\",\"pages\":\"525-528\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-07-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国癌症杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3969/J.ISSN.1007-3969.2014.07.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国癌症杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/J.ISSN.1007-3969.2014.07.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Intermittent administration of valacyclovir is effective for prevention of herpes zoster events in patients with multiple myeloma treated with bortezomib
期刊介绍:
The journal of China Oncology (ISSN 1007-3639, CN 31-1727/R) started in 1991, is a peer-reviewed monthly publication, integrating scientific information from global sources for all oncologic specialties. It is an open access monthly published journal in Chinese and English. The competent authorities of China Oncology is the Ministry of Education of the People’s Republic of China. China Oncology is hosted by one of the most prestigious comprehensive cancer centers, the Fudan University Shanghai Cancer Center.
Database Index
At present, China Oncology is indexed in the following most powerful database: SCOPUS, DOAJ, Chemical Abstracts (CAS), EMBASE, EBSCO, Japan Science and Technology Database (JST), Index of Copernicus International (ICI) and Western Pacific Region Index Medicus (WPRIM), Ulrich's Periodical Directory, Chinese Science Citation Database (CSCD), A Guide to the Core Journal of China, Chinese Scientific and Technical Papers and Citations Database (CSTPCD), Chinese Academic Journal Comprehensive Evaluation Database (CAJCED), Chinese Medical Current Content (CMCC), Chinese Medical Citation Index (CMCI),Chinese Biological Abstracts (CBA), GoOA,COAJ, Level A of Fudan University degree and Graduate Education Domestic Journals Guideline, Research Center for Chinese Science Evaluation (RCCSE), World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2023). Besides, China Oncology continuously acquired Certificate of Outstanding S&T Journals of China (F5000) since 2017.